Literature DB >> 8491182

Strategies for differential sensory responses mediated through the same transmembrane receptor.

R Yaghmai1, G L Hazelbauer.   

Abstract

Trg mediates chemotaxis of Escherichia coli to galactose and ribose by recognition of respective, sugar-occupied binding proteins. Although both attractants act through one transmembrane receptor, maximal response is approximately 50% greater to ribose. This phenomenon was investigated by mutational analysis of a 20-residue segment of Trg implicated in ligand interaction and signalling. Among 17 defective receptors, responses to the two chemoattractants were reduced equivalently for seven and differentially for 10, in some cases reversing the preference order. Mutational substitutions with equivalent effects occurred throughout the segment, but those with a greater effect on galactose or ribose response were segregated to the amino-terminal two-thirds or the carboxy-terminal one-third, respectively, a segregation corresponding in large part to a functional division based on signalling phenotypes. A model for binding protein-mediated recognition revealed two strategies for differential responses. The wild-type preference for ribose probably reflects a balance of receptor affinities and a limiting supply of binding proteins. Mutants with reversed preference probably have differentially reduced receptor affinities and those with an accentuated ribose preference probably have altered signalling abilities. Two-step recognition of ligand allows functional separation of detection and response.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491182      PMCID: PMC413410          DOI: 10.1002/j.1460-2075.1993.tb05838.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  27 in total

1.  Ligand occupancy mimicked by single residue substitutions in a receptor: transmembrane signaling induced by mutation.

Authors:  R Yaghmai; G L Hazelbauer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

2.  Proteolytic fragments identified with domains of the aspartate chemoreceptor.

Authors:  S L Mowbray; D L Foster; D E Koshland
Journal:  J Biol Chem       Date:  1985-09-25       Impact factor: 5.157

3.  Mutants in transmission of chemotactic signals from two independent receptors of E. coli.

Authors:  G L Hazelbauer; S Harayama
Journal:  Cell       Date:  1979-03       Impact factor: 41.582

4.  Isolation and complementation of mutants in galactose taxis and transport.

Authors:  G W Ordal; J Adler
Journal:  J Bacteriol       Date:  1974-02       Impact factor: 3.490

5.  A method for measuring chemotaxis and use of the method to determine optimum conditions for chemotaxis by Escherichia coli.

Authors:  J Adler
Journal:  J Gen Microbiol       Date:  1973-01

6.  Role of the galactose binding protein in chemotaxis of Escherichia coli toward galactose.

Authors:  G L Hazelbauer; J Adler
Journal:  Nat New Biol       Date:  1971-03-24

7.  Dependence of maltose transport and chemotaxis on the amount of maltose-binding protein.

Authors:  M D Manson; W Boos; P J Bassford; B A Rasmussen
Journal:  J Biol Chem       Date:  1985-08-15       Impact factor: 5.157

8.  Transient response to chemotactic stimuli in Escherichia coli.

Authors:  H C Berg; P M Tedesco
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

9.  Chemotaxis toward sugars in Escherichia coli.

Authors:  J Adler; G L Hazelbauer; M M Dahl
Journal:  J Bacteriol       Date:  1973-09       Impact factor: 3.490

10.  Receptor interactions in a signalling system: competition between ribose receptor and galactose receptor in the chemotaxis response.

Authors:  P G Strange; D E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

View more
  8 in total

1.  Substitutions in the periplasmic domain of low-abundance chemoreceptor trg that induce or reduce transmembrane signaling: kinase activation and context effects.

Authors:  B D Beel; G L Hazelbauer
Journal:  J Bacteriol       Date:  2001-01       Impact factor: 3.490

2.  Site-directed spin labeling of a bacterial chemoreceptor reveals a dynamic, loosely packed transmembrane domain.

Authors:  Alexander Barnakov; Christian Altenbach; Ludmila Barnakova; Wayne L Hubbell; Gerald L Hazelbauer
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

3.  Differences in signalling by directly and indirectly binding ligands in bacterial chemotaxis.

Authors:  Silke Neumann; Clinton H Hansen; Ned S Wingreen; Victor Sourjik
Journal:  EMBO J       Date:  2010-09-10       Impact factor: 11.598

4.  Mutational analysis of a transmembrane segment in a bacterial chemoreceptor.

Authors:  J W Baumgartner; G L Hazelbauer
Journal:  J Bacteriol       Date:  1996-08       Impact factor: 3.490

5.  Detecting the conformational change of transmembrane signaling in a bacterial chemoreceptor by measuring effects on disulfide cross-linking in vivo.

Authors:  A G Hughson; G L Hazelbauer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

6.  Transmembrane signaling characterized in bacterial chemoreceptors by using sulfhydryl cross-linking in vivo.

Authors:  G F Lee; M R Lebert; A A Lilly; G L Hazelbauer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

7.  Transmembrane signalling by a hybrid protein: communication from the domain of chemoreceptor Trg that recognizes sugar-binding proteins to the kinase/phosphatase domain of osmosensor EnvZ.

Authors:  J W Baumgartner; C Kim; R E Brissette; M Inouye; C Park; G L Hazelbauer
Journal:  J Bacteriol       Date:  1994-02       Impact factor: 3.490

8.  The integrity of the periplasmic domain of the VirA sensor kinase is critical for optimal coordination of the virulence signal response in Agrobacterium tumefaciens.

Authors:  Gauri R Nair; Xiaoqin Lai; Arlene A Wise; Benjamin Wonjae Rhee; Mark Jacobs; Andrew N Binns
Journal:  J Bacteriol       Date:  2011-01-07       Impact factor: 3.490

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.